We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+28.58%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$3.75B
AUM Growth
+$525M
Cap. Flow
-$632M
Cap. Flow %
-16.88%
Top 10 Hldgs %
81.24%
Holding
87
New
11
Increased
6
Reduced
26
Closed
13

Top Buys

Rank Stock Value
1
NTES icon
NetEase
NTES
+$24M
2
IBKR icon
Interactive Brokers
IBKR
+$10.7M
3
HUNT
Hunter Maritime Acquisition Corp. Common Stock
HUNT
+$9.81M
4
MMYT icon
MakeMyTrip
MMYT
+$7.36M
5
RICE
Rice Energy Inc.
RICE
+$5.75M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$21.2M
2
IBB icon
iShares Biotechnology ETF
IBB
+$18.1M
3
EQC
Equity Commonwealth
EQC
+$17.3M
4
PYPL icon
PayPal
PYPL
+$14.5M
5
HUNTU
Hunter Maritime Acquisition Corp. Unit
HUNTU
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 62.84%
2 Consumer Discretionary 2.9%
3 Communication Services 2.74%
4 Financials 1.95%
5 Energy 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIOX
1
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.74B 46.44%
9,375,000
– –
MYOV
2
DELISTED
Myovant Sciences Ltd.
MYOV
$436M 11.63%
37,231,342
– –
XBI icon
3
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$309M 8.24%
4,000,000
-1,829,700
-31% -$130M
MMYT icon
4
MakeMyTrip
MMYT
$4.67B
$73.5M 1.96%
2,264,837
+211,823
+10% +$7.36M
ABUS icon
5
Arbutus Biopharma
ABUS
$865M
$57.6M 1.54%
16,013,540
– –
IBB icon
6
iShares Biotechnology ETF
IBB
$9.31B
$53M 1.41%
512,511
-183,924
-26% -$18.1M
AGN.PRA
7
DELISTED
Allergan plc
AGN.PRA
$43.3M 1.16%
50,000
– –
NYT icon
8
New York Times
NYT
$11.6B
$26M 0.69%
1,469,488
-377,334
-20% -$6.2M
NTES icon
9
NetEase
NTES
$76.5B
$25.2M 0.67%
+418,950
New +$24M
KMX icon
10
CarMax
KMX
$8.27B
$23.4M 0.62%
370,402
-39,687
-10% -$2.4M
KANG
11
DELISTED
iKang Healthcare Group, Inc.
KANG
$20.4M 0.55%
1,665,866
+105,023
+7% +$1.52M
BFH icon
12
Bread Financial
BFH
$4.21B
$20.1M 0.54%
97,966
-8,245
-8% -$1.64M
RICE
13
DELISTED
Rice Energy Inc.
RICE
$19.5M 0.52%
732,317
+259,017
+55% +$5.75M
GS icon
14
Goldman Sachs
GS
$313B
$18.2M 0.49%
81,940
– –
AVXS
15
DELISTED
AveXis, Inc. Common Stock
AVXS
$18.1M 0.48%
220,356
– –
AGEN
16
Agenus
AGEN
$249M
$17.6M 0.47%
229,181
+20,361
+10% +$1.43M
ATEX icon
17
Anterix
ATEX
$1.83B
$17.1M 0.46%
839,236
-54,795
-6% -$1.27M
NRE
18
DELISTED
NorthStar Realty Europe Corp.
NRE
$16.9M 0.45%
1,356,743
-307,620
-18% -$3.72M
TWX
19
DELISTED
Time Warner Inc
TWX
$16.2M 0.43%
161,518
– –
XLRN
20
DELISTED
Acceleron Pharma
XLRN
$14.6M 0.39%
480,437
– –
CMBT
21
CMB.TECH NV
CMBT
$4.57B
$13.8M 0.37%
1,752,883
+401,959
+30% +$3.1M
AMBA icon
22
Ambarella
AMBA
$2.99B
$12.1M 0.32%
248,777
-38,800
-13% -$2.15M
HD icon
23
Home Depot
HD
$332B
$11.8M 0.32%
77,000
– –
IBKR icon
24
Interactive Brokers
IBKR
$40.9B
$11.2M 0.3%
+1,200,000
New +$10.7M
NAT icon
25
PUT
Nordic American Tanker
NAT
$1.37B
$10.4M 0.28%
1,653,221
+840,571
+103% +$5.9M
1
2 3

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q2 2017 Portfolio in Review

As of Q2 2017, QVT Financial held 87 positions worth $3.75B, up 16% from $3.22B the previous quarter. Its ten largest holdings account for 81% of the portfolio.

QVT Financial withdrew a net $632M in Q2 2017, closing 13 positions and reducing 26 holdings. Its most notable exit was Intel, an estimated $21.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 56% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, QVT Financial opened a new position in NetEase worth $25.2M.

  • QVT Financial's largest Q2 2017 buy was NetEase: 418,950 shares worth $25.2M.
  • QVT Financial added most to MakeMyTrip in Q2 2017, an estimated $7.36M increase.
  • QVT Financial's biggest Q2 2017 reduction was iShares Biotechnology ETF, cutting an estimated $18.1M.
  • QVT Financial fully exited Intel in Q2 2017, selling an estimated $21.2M.
  • QVT Financial's ten largest holdings make up 81% of its $3.75B portfolio in Q2 2017.
  • QVT Financial opened 11 new positions and closed 13 in Q2 2017.
  • QVT Financial's portfolio value rose 16% quarter-over-quarter to $3.75B.

Based on QVT Financial's 13F filing for Q2 2017, filed 14 Aug 2017.